Hemoglobinopathy Market is Anticipated to Witness Growth Owing to Advanced Diagnostic Techniques
The Hemoglobinopathy Market encompasses a broad array of diagnostic assays, screening kits, instruments and reagents designed to detect inherited hemoglobin disorders such as sickle cell disease, β-thalassemia and other hemoglobin variants. Traditional methods like high-performance liquid chromatography (HPLC), capillary electrophoresis and PCR-based techniques have long served as the backbone of diagnosis, offering reliable quantification of hemoglobin fractions and variant identification.
Recent innovations build on these foundations by integrating next-generation sequencing (NGS) approaches, enabling comprehensive mutation profiling with higher throughput and sensitivity.
Get More Insights On Hemoglobinopathy Market
https://www.zupyak.com/p/45579....52/t/hemoglobinopath
